An Italian Observation of Antiretroviral Treatment in Participants Taking Darunavir/ Cobicistat Plus Emtricitabine and Tenofovir Alafenamide Fumarate

NCT03577470 · clinicaltrials.gov ↗

COMPLETED

Status

246

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Immunodeficiency Virus (HIV)

Interventions

DRUG: D/C/F/TAF Fixed-Dose Combination (FDC)

Sponsor

Janssen-Cilag S.p.A.